Latest Breaking News On - Spero therapeutic third quarter - Page 1 : comparemela.com

Spero Therapeutics, Inc. (NASDAQ:NASDAQ:SPRO) Q3 2022 Earnings Conference Call November 14, 2022 04:30 PM ET Company Participants Ted Jenkins - Vice President, Investor Relations &.

Louise chenTed jenkinsAnkit mahadeviaKamal hamedGavin clark gartnerCompany participantsTrademark officeSpero therapeutics incSpero therapeuticsConference call novemberInvestor relationsStrategic financeSpero therapeutic third quarterResults conferenceVice president investor relationsSpero therapeutic